SNTI - Senti Biosciences GAAP EPS of -$0.38 beats by $0.12 revenue of $1.77M beats by $0.84M
- Senti Biosciences press release ( NASDAQ: SNTI ): Q3 GAAP EPS of -$0.38 beats by $0.12 .
- Revenue of $1.77M (+60.9% Y/Y) beats by $0.84M .
- As of September 30, 2022, Senti Bio held cash and cash equivalents of $114.9 million, which the Company believes is sufficient to fund operations into 2024
- Shares +1.75% PM.
For further details see:
Senti Biosciences GAAP EPS of -$0.38 beats by $0.12, revenue of $1.77M beats by $0.84M